- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01617382
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed (HIPEC)
Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed
Study Overview
Status
Detailed Description
To register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC. In this surgical intervention, the abdominal cavity is macroscopically cleared of tumor, by removing all visible tumor nodules, and is subsequently rinsed with hyperthermic (heated) chemotherapy, aiming to destroy all residual invisible tumor cells that might have stayed behind after the debulking.
The eventual aim of this procedure is to improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Isabelle B Terrasson
- Phone Number: +32 16 340837
- Email: isabelle.terrasson@uzleuven.be
Study Locations
-
-
Flemish Brabant
-
Leuven, Flemish Brabant, Belgium, 3000
- Recruiting
- University Clinics Gasthuisberg
-
Contact:
- Isabelle B Terrasson
- Phone Number: +32 16 340837
- Email: isabelle.terrasson@uzleuven.be
-
Contact:
- Daphne Hompes, MD
- Phone Number: +32 16 341826
- Email: daphne.hompes@uzleuven.be
-
Principal Investigator:
- André JL D'HOORE, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Registry
Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.
Time Frame: Follow-up over a time period of at least 5 years
|
Follow-up over a time period of at least 5 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: André JL D'Hoore, PhD, University Clinics Gasthuisberg Department of Abdominal Surgery
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Adenocarcinoma
- Neoplasms, Glandular and Epithelial
- Peritoneal Diseases
- Wounds and Injuries
- Digestive System Neoplasms
- Abdominal Neoplasms
- Body Temperature Changes
- Heat Stress Disorders
- Neoplasms, Cystic, Mucinous, and Serous
- Adenoma
- Neoplasms, Mesothelial
- Adenocarcinoma, Mucinous
- Carcinoma
- Peritoneal Neoplasms
- Hyperthermia
- Fever
- Mesothelioma
- Pseudomyxoma Peritonei
Other Study ID Numbers
- S-54350
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pseudomyxoma Peritonei
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingPseudomyxoma PeritoneiItaly
-
Maimónides Biomedical Research Institute of CórdobaActive, not recruitingPseudomyxoma PeritoneiSpain
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Associazione Italiana per la Ricerca sul CancroCompletedColorectal Cancer | Pseudomyxoma PeritoneiItaly
-
University of SouthamptonHampshire Hospitals NHS Foundation TrustWithdrawnRecovery | Pseudomyxoma Peritonei | Cytoreductive SurgeryUnited Kingdom
-
Mucpharm Pty LtdWake Forest University Health Sciences; Catharina Ziekenhuis Eindhoven; Hospital... and other collaboratorsNot yet recruitingPseudomyxoma Peritonei | Peritoneal Cancer | Mucinous Adenocarcinoma | Mucinous Tumor
-
M.D. Anderson Cancer CenterActive, not recruitingGastrointestinal NeoplasmsUnited States
-
Washington University School of MedicineTerminated
-
Stony Brook UniversityUniversity of Iowa; Ipsen; Barbara Ann Karmanos Cancer InstituteCompletedGastric Cancer | Colorectal Cancer | Mesothelioma | Pseudomyxoma Peritonei | Peritoneal Cancer | Mucinous Adenocarcinoma | Primary Peritoneal Carcinoma | Mucinous TumorUnited States
-
Mercy Medical CenterActive, not recruitingPseudomyxoma Peritonei | Appendiceal NeoplasmsUnited States